AVI Polymers Launches Ashwini Healthcare AI with 5,620 Users and ₹12 Cr ARR Target
AVI Polymers Ltd has officially introduced Ashwini Healthcare AI, a dedicated HealthTech SaaS platform that has already secured a waitlist of over 5,620 organic users. The company expects to convert this early interest into a recurring revenue stream with a baseline Year-1 Annual Recurring Revenue projected between ₹6.00 Lakhs and ₹9.00 Lakhs.
Privi Speciality Chemicals Receives NSE No Objection for Amalgamation Scheme
Privi Speciality Chemicals has cleared a major regulatory milestone by obtaining a 'no objection' observation letter from the National Stock Exchange of India for its proposed merger. The scheme involves integrating Privi Fine Sciences and Privi Biotechnologies into the parent entity to streamline operations and enhance group synergies.